Global Standardized Financials

83.22 0.41(0.49%)09/16/2024
Gilead Sciences, Inc. (GILD)

Income Statement
(Values in USD Thousands)
 2024-06-30 2024-03-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30
Net Income1,614,000-4,170,0002,180,0001,045,000
Revenue6,949,0006,686,0007,050,0006,599,000
Cost Of Revenue1,544,0001,552,0001,565,0001,442,000
gross Profit5,405,0005,134,0005,485,0005,157,000
Operating Expenses2,717,0002,832,0002,772,0003,256,000
Selling General and Administrative Expenses1,369,0001,362,0001,315,0001,849,000
Research and Development Expenses1,348,0001,470,0001,457,0001,407,000
Other Expenses-355,00091,000-72,000152,000
Cost And Expenses4,261,0004,384,0004,337,0004,698,000
Operating Income2,688,0002,302,0002,623,0001,665,000
Income Tax Expense438,000-315,000146,000549,000
Income Before Tax2,053,000-4,486,0002,318,0001,588,000
Earning Per Share Basic1.29-3.341.750.84
Earning Per Share Diluted1.29-3.341.730.83
weighted Average Shares Outstanding1,247,0001,247,0001,248,0001,249,000
weighted Average Shares Outstanding (Diluted)1,251,0001,247,0001,257,0001,258,000
Gross Margin0.780.770.780.78
EBIT Margin0.490.450.370.31
Profit Margin0.23-0.620.310.16
EBITDA3,382,0002,992,0002,641,0002,054,000
Earning Before Tax Margin0.30-0.670.330.24